Real-world STRIVE Study to Evaluate Liraglutide 3.0mg's Effectiveness and Cost-Impact in Severe Obesity
Saxenda in Obesity Services (STRIVE Study)
Abstract
The STRIVE study is a two-year, real-world RCT evaluating Liraglutide 3.0mg's effectiveness and cost-impact in severe obesity management.